EP3408295
Lyfjasamsetning sem inniheldur tvísértækar mótefnissmíðar
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
25.1.2017EP published:
26.7.2023EP application number:
17702801.6
EP translation filed:
18.9.2023Grant published:
15.10.2023EPO information:
European Patent Register
Max expiry date:
24.1.2037Expiry date:
24.1.2027Next due date:
31.1.2027
Title in English:
PHARMACEUTICAL COMPOSITION COMPRISING BISPECIFIC ANTIBODY CONSTRUCTSLanguage of the patent:
English
Timeline
Today
25.1.2017EP application
26.7.2023EP Publication
18.9.2023Translation submitted
15.10.2023Registration published
24.1.2027Expires
Owner
Name:
Amgen Research (Munich) GmbHAddress:
Staffelseestrasse 2, 81477 München, DE
Name:
Amgen Inc.Address:
One Amgen Center Drive, Thousand Oaks, California 91320-1799, US
Inventor
Name:
KANAPURAM, SekharAddress:
Thousand Oaks, California 91320, US
Name:
LATYPOV, RamilAddress:
Wellesley, Massachusetts 02481, US
Name:
THANGARAJ, BalakumarAddress:
Lexington, Massachusetts 02421, US
Name:
POMPE, CorneliusAddress:
81477 Munich, DE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201662286552 PDate:
25.1.2016Country:
US
Classification
Categories:
C07K 16/28, A61K 39/395, A61K 47/00
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 31.1.2024
Expires: 24.1.2025
Payer: Árnason Faktor ehf.
Number: 9
Paid: 8.1.2025
Expires: 24.1.2026
Payer: Árnason Faktor ehf.
Number: 10
Paid: 12.1.2026
Expires: 24.1.2027
Payer: Árnason Faktor ehf.